Delivery Order SPE2DE21D7010-SPE2D625F1BAJ
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,681.90 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 24, 2025. This fixed-price contract with economic price adjustment mechanisms is set to be completed by July 25, 2025. The award represents an open market procurement with no set-aside designation, consistent with Nuvasive's established competitive success in federal healthcare...
- Nuvasive, Inc. has been awarded a $8,533 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency, with an award date of July 21, 2025, and ultimate completion by July 22, 2025. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and involves delivery to San Diego, California. This delivery order was awarded without set-aside designation, indicating open competition. Nuvasive specializes in advanced spinal surgery...
- Nuvasive, Inc. was awarded a $9,368 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 3, 2025. This fixed-price contract with economic price adjustment mechanisms represents a non-competitive procurement with no set-aside designation. Nuvasive, a San Diego-based medical device company specializing in spinal surgery products and services, will deliver advanced spinal medical technologies, implants, and...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- Nuvasive, Inc. was awarded a fixed-price delivery order valued at $5,278.80 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 28, 2025, with an ultimate completion date of August 15, 2025. The contract, designated as PROPEL DBM, will be performed in San Diego, California, and carries no set-aside designation, indicating open market competition. This delivery order falls under Nuvasive's existing contractual relationship with the DLA, which supplies advanced spinal medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a $13,877.52 fixed-price delivery order (Contract No. 4569002143) by the Defense Logistics Agency Medical Supply Chain on August 4, 2025. The delivery order, designated "SMALL INTERLOCK II," includes economic price adjustment provisions and calls for performance in San Diego, California, with an ultimate completion date of August 5, 2025. This award was made without...
- The U.S. Defense Logistics Agency (DLA) awarded a fixed-price delivery order contract worth $43,183.03 to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, which has an ultimate completion date of March 29, 2024, was placed against an existing indefinite-delivery/indefinite-quantity (IDIQ) vehicle or blanket purchase agreement (BPA) held by Nuvasive. This BPA, valued at $8 million, was awarded by the Defense Health Agency (DHA) and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $4,700.04 fixed-price delivery order contract to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract has an ultimate completion date of May 29, 2024 and is not set aside. Nuvasive, which is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, will provide a range of spinal implants, instruments, biologics, and related equipment to support...
- Nuvasive, Inc. was awarded a $71,959.93 fixed-price delivery order (4568882953, RELINE-ONE) by the Defense Logistics Agency Medical Supply Chain on July 24, 2025, with an ultimate completion date of August 13, 2025. The contract, which carries no set-aside designation, will be performed in San Diego, California. This delivery order is issued under Nuvasive's existing indefinite delivery/indefinite quantity (IDIQ) contract vehicle, likely the $8 million Blanket Purchase Agreement with the Defense...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a $8,533 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on July 24, 2025. The delivery order, designated as SIMPLIFY, carries an ultimate completion date of August 13, 2025 and includes economic price adjustment provisions. This award was issued competitively with no set-aside designation, reflecting Nuvasive's established capability...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F1BAJDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and technologies, was awarded a delivery order valued at $8,533.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 14, 2025. This fixed-price delivery order with economic price adjustment mechanism does not utilize any set-aside designation, indicating the contract was awarded through open market competition. The contract is scheduled for completion by August 15, 2025, and represents a continuation of Nuvasive's ongoing supply relationship with federal healthcare agencies through the DLA's Medical Supply Chain procurement channel. This delivery order falls under Nuvasive's broader procurement relationships with the Department of Defense and Defense Health Agency, including the company's participation in an $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency functioning as an Indefinite Delivery/Indefinite Quantity vehicle through March 2027. Nuvasive operates as a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and supplies specialized spinal medical technologies, implants, instruments, and biologics to support complex orthopedic and neurosurgical procedures at military and veteran healthcare facilities. The company's contract awards with DLA typically involve small to moderate-value delivery orders supporting the military health system's advanced medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/14/25 |